Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Blocking a Little-Known Protein May Offer New Hope for Devastating Lung Disease

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung-scarring disease. Their findings, demonstrated across cell cultures, preclinical models, and samples of human lung tissue, show that blocking Epac1 can slow the progression of the disease. Published in the July 7 online issue of European Respiratory Journal [https://doi.org/10.1183/13993003.02250-2024], the work could pave the way for a new class of treatments to help patients with this currently incurable condition.

July 15, 2025


July 16 2025

July 15 2025

July 14 2025

July 13 2025

July 12 2025

July 11 2025

July 10 2025

July 9 2025

July 8 2025

July 7 2025

July 6 2025

July 5 2025

July 4 2025

July 3 2025

July 2 2025